biochanin ABiochanin A
A red clover isoflavone: a micromolar FAAH inhibitor, with no affinity for CB1 or CB2.
C₁₆H₁₂O₅
CAS 491-80-5
- Family
- ECS pharmacological toolEnzyme inhibitor
- Molar mass
- 284.26 g/mol
Updated on
In plain terms
Biochanin A is a molecule from red clover, a legume. It does not come from hemp and has no structural relationship with CBD. In the laboratory, it slows the enzyme that breaks down anandamide, a cannabinoid the body makes itself; in humans, the amounts measured in the blood after a red clover supplement remain well below the concentrations active in vitro.
Receptors and activity
Target network
- Activates
- Blocks or inhibits
The lower the cited value, the closer the target sits to biochanin A: one ring per factor of 100. A target with no measured value stays on the edge.
Where these targets live
Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of biochanin A.
FAAHFAAH found in 7 regions of the body
- CortexpresentCortical pyramidal neurons1
- Basal gangliapresentStriatal neurons1
- HypothalamuspresentPresent in hypothalamic nuclei1
- CerebellumpresentPurkinje cells and cerebellar layers1
- BrainstempresentInferior olivary nuclei1
- Adipose tissuepresentExpressed in mature adipocytes2
- BonepresentPresent on osteoclasts3
Map sources
- Romero J et al. Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study. Brain Res Mol Brain Res, 2002 (new tab)
- Engeli S et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes, 2005 (new tab)
- Rossi F et al. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption. Bone, 2009 (new tab)
Cited values
- FAAHInhibitorIC50 = 2.4 µM · human27 out of 100
Thors et al. 2010, Br J Pharmacol (new tab) · hydrolysis of 0.5 µM AEA; IC50 of 1.4 µM (rat) and 1.8 µM (mouse); mixed inhibition, slope Ki 1.1 µM and intercept Ki 8.2 µM (rat FAAH)
- URB597-sensitive cellular anandamide retentionInhibitorIC50 = 220 nM · rat44 out of 100
Thors et al. 2010, Br J Pharmacol (new tab) · [3H]AEA retention, RBL2H3 cells
- PPARα and PPARγAgonistno measured value cited
EC50 of 1 to 4 µM in reporter gene assays; PPARα/PPARγ ratio close to 1 to 1 with the full-length receptors (Shen 2006)
- Aromatase (CYP19)Inhibitorno measured value cited
Inhibition of activity in MCF-7 cells expressing CYP19; fall in CYP19 mRNA at 25 µM in SK-BR-3 cells (Wang 2008)
Measured effects
Not characterised. No placebo-controlled human trial has measured the effects of biochanin A, so no level is shown.
Levels computed from placebo-controlled human trials: difference from placebo on 100, at the dose and route stated. Read the method
Pharmacology
Described in 2010 as a natural FAAH inhibitor, biochanin A blocks anandamide hydrolysis with IC50 values of 1.4 µM (rat), 1.8 µM (mouse) and 2.4 µM (human enzyme), by mixed inhibition, with no effect on FAAH-2 and weak binding to the CB1 and CB2 receptors (Thors 2010). In mice, given intravenously (15 mg/kg), it did not raise brain anandamide but modestly potentiated its effects, and the authors conclude to FAAH inhibition in vitro and in the periphery. In 2022, Zada et al. measured an IC50 of 2.1 µM and, in mice treated for 14 days at 30 mg/kg, an increase in prefrontal cortex anandamide. Its effects cannot be attributed to the endocannabinoid system alone: it also activates PPARα and PPARγ (Shen 2006) and inhibits aromatase (Wang 2008). In humans, after 80 mg per day of a red clover extract, peak plasma concentrations of biochanin A and formononetin were about 48 ng/mL, i.e. 170 nM (Howes 2002, cited by Thors 2010), well below the IC50 values measured on FAAH. No clinical trial has assessed this endocannabinoid activity.
Key sources.
- Thors et al. 2010, Br J Pharmacol: natural FAAH inhibitor (new tab)PMID 20590565
- Zada et al. 2022, Pharmacol Res Perspect: FAAH and isoflavonoids (new tab)PMID 36029006
- Shen et al. 2006, J Nutr: activation of PPARα and PPARγ (new tab)PMID 16549448
- Wang et al. 2008, Br J Nutr: aromatase inhibition (new tab)PMID 17761019
- Moon et al. 2006, AAPS J: pharmacokinetics in the rat (new tab)PMID 17025260
- Roberts et al. 2004, J Agric Food Chem: demethylation by CYP1A1 and CYP1B1 (new tab)PMID 15479032
- Howes et al. 2002, J Altern Complement Med: pharmacokinetics of a red clover extract (new tab)PMID 12006121
- Li et al. 2016, Front Plant Sci: 4'-O-methylation of isoflavones (new tab)PMID 27379141
- PubChem, Compound Summary CID 5280373 (biochanin A) (new tab)
History
- Source
- A natural product of legumes, absent from cannabis. With formononetin, biochanin A is one of the predominant isoflavones of red clover (Trifolium pratense) (Roberts 2004), and it is found in the red clover extracts sold as food supplements (Wang 2008).
Origin
Research tool
The isoflavone pathway specific to legumes. The 4'-O-methylation that distinguishes biochanin A from genistein has not been characterised specifically for it; for formononetin, its analogue, the 4'-O-methyltransferases described act either at the 2-hydroxyisoflavanone intermediate stage or directly on the isoflavone, as in Pueraria lobata (Li 2016).
Legal framework
- European Union
No European Union instrument and no schedule of the 1961 and 1971 United Nations conventions covers biochanin A, a dietary constituent of legumes. An isolated, concentrated ingredient without a history of consumption would fall under Regulation (EU) 2015/2283 on novel foods.
- France
Not classified as a narcotic in France: a plant isoflavone without a cannabinoid skeleton, biochanin A is named in no schedule of the arrêté of 22 February 1990 and does not fall within the generic class of the benzo[c]chromene nucleus (ANSM decisions of 2024). Food supplements containing it fall under food law.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Classification
Family, origin and source verification
- Family
ECS pharmacological tool › Enzyme inhibitor
- Verification
Every fact on this entry was checked against its primary sources on 20 October 2026.
- Wikipedia (English)
Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.
References
- Thors et al. 2010, Br J Pharmacol: natural FAAH inhibitor (new tab)PMID 20590565
- Zada et al. 2022, Pharmacol Res Perspect: FAAH and isoflavonoids (new tab)PMID 36029006
- Shen et al. 2006, J Nutr: activation of PPARα and PPARγ (new tab)PMID 16549448
- Wang et al. 2008, Br J Nutr: aromatase inhibition (new tab)PMID 17761019
- Moon et al. 2006, AAPS J: pharmacokinetics in the rat (new tab)PMID 17025260
- Roberts et al. 2004, J Agric Food Chem: demethylation by CYP1A1 and CYP1B1 (new tab)PMID 15479032
- Howes et al. 2002, J Altern Complement Med: pharmacokinetics of a red clover extract (new tab)PMID 12006121
- Li et al. 2016, Front Plant Sci: 4'-O-methylation of isoflavones (new tab)PMID 27379141
- PubChem, Compound Summary CID 5280373 (biochanin A) (new tab)
Identifiers
Names
- Common name
- Biochanin A
- IUPAC name
- 5,7-dihydroxy-3-(4-methoxyphenyl)chromen-4-one
- Other names
- biochanine A · olmelin · pratensol
Identifiers
- Formula
- C₁₆H₁₂O₅
- CAS
- 491-80-5
- PubChem CID
- 5280373(new tab)
- InChIKey
- WUADCCWRTIWANL-UHFFFAOYSA-N
- SMILES
- COC1=
CC= C(C= C1) C2= COC3= CC(= CC(= C3C2= O) O) O
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.